GNG Research GNG Research

Tenaya Therapeutics Inc (TNYA) Stock Analysis

Tenaya Therapeutics Inc (TNYA) is a publicly traded company in the HEALTHCARE sector. It trades at $0.87, carries a market capitalization of $184.45M. This page summarizes the public market data, fundamentals, and frequently asked questions for TNYA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

  • Price: $0.87
  • Market Cap: $184.45M
  • EPS: $-0.41
  • 52-Week High: $2.35
  • 52-Week Low: $0.53

Market Sentiment

Tenaya Therapeutics Inc currently has a Bullish sentiment score of 0.26.

About Tenaya Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Tenaya Therapeutics Inc (TNYA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TNYA.

Frequently Asked Questions

Does TNYA pay dividends?

Tenaya Therapeutics Inc (TNYA) does not currently pay a regular dividend.

What is TNYA's market cap?

Tenaya Therapeutics Inc (TNYA) has a market capitalization of $184.45M with a current stock price of $0.87.